Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Shota Fukuoka | Researchclopedia

Back to researchers

Shota Fukuoka

University of Fukui ORCID

175

Works

4,779

Citations

21

h-index

35

i10-index

Research Topics

Colorectal Cancer Treatments and Studies Gastric Cancer Management and Outcomes Colorectal Cancer Surgical Treatments

Affiliations

University of Fukui2024–2025

Hokkaido University1994–1994

Juntendo University2016–2016

National Cancer Center2021–2021

Institute of Cancer Research2023–2023

Top Works

PD-1 <sup>+</sup> regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer

Takahiro Kamada,Yosuke Togashi,et al.

20191,005 citations

Colorectal and Anal Carcinomas

Cancer Immunotherapy and Biomarkers

Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)

Shota Fukuoka,Hiroki Hara,et al.

2020902 citations

The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies

Shogo Kumagai,Yosuke Togashi,et al.

2020797 citations

Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments

Shogo Kumagai,Shohei Koyama,et al.

2022785 citations

Lenvatinib plus pembrolizumab in patients with advanced gastric cancer in the first-line or second-line setting (EPOC1706): an open-label, single-arm, phase 2 trial

Akihito Kawazoe,Shota Fukuoka,et al.

2020265 citations

A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer

Akihito Kawazoe,Kohei Shitara,et al.

2015105 citations

Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study

Toshikazu Moriwaki,Shota Fukuoka,et al.

2017104 citations

Regorafenib plus nivolumab in patients with advanced gastric (GC) or colorectal cancer (CRC): An open-label, dose-finding, and dose-expansion phase 1b trial (REGONIVO, EPOC1603).

Shota Fukuoka,Hiroki Hara,et al.

201969 citations

Short-term results of VOLTAGE-A: Nivolumab monotherapy and subsequent radical surgery following preoperative chemoradiotherapy in patients with microsatellite stable and microsatellite instability-high locally advanced rectal cancer.

Satoshi Yuki,Hideaki Bando,et al.

202068 citations